Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...
The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...
According to the FDA, If consumers have an allergy or sensitivity to milk, they should not consume the product and discard it ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...
The Food and Drug Administration has upgraded its classification of a broccoli recall initially reported in late December, ...
The U.S. Food and Drug Administration has labeled the broccoli recall as a Class I, the highest risk level issued by the ...
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...